ArticleOncoTargets and therapy2018

Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer.

Qiong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.